Skip to menu Skip to content Skip to footer
Professor

Andrew Clouston

Email: 

Overview

Availability

Professor Andrew Clouston is:
Available for supervision

Qualifications

  • Bachelor of Medicine and Surgery and Medical Science, The University of Queensland
  • Royal College of Pathologists of Australasia, Royal College of Pathologists of Australasia

Works

Search Professor Andrew Clouston’s works on UQ eSpace

354 works between 1993 and 2025

321 - 340 of 354 works

1999

Journal Article

Case report: Lamivudine therapy for submassive hepatic necrosis due to reactivation of Hepatitis B following chemotherapy

Maguire, C. M., Crawford, D. H. G., Hourigan, L. F., Clouston, A. D., Walpole, E. T. and Powell, E. E. (1999). Case report: Lamivudine therapy for submassive hepatic necrosis due to reactivation of Hepatitis B following chemotherapy. Journal of Gastroenterology and Hepatalogy, 14 (8), 801-803. doi: 10.1046/j.1440-1746.1999.01961.x

Case report: Lamivudine therapy for submassive hepatic necrosis due to reactivation of Hepatitis B following chemotherapy

1999

Conference Publication

Serum hyaluronic acid and collagen type IV as markers of hepatic fibrosis in patients with haemochromatosis and other chronic liver diseases American Association for the Study of Liver Diseases (AASLD) 50th annual meeting. Texas, USA. November 5-9, 1999.

Ramm, G.A., Murphy, T.L., Fanning, P.A., Clouston, A.D., Anderson, G.J. and Crawford, D.H. (1999). Serum hyaluronic acid and collagen type IV as markers of hepatic fibrosis in patients with haemochromatosis and other chronic liver diseases American Association for the Study of Liver Diseases (AASLD) 50th annual meeting. Texas, USA. November 5-9, 1999.. 50th Annual Meeting American Association for the Study of Liver Disease, Dallas, TX, United States, 5-9 November 1999. Hoboken, NJ, United States: John Wiley & Sons.

Serum hyaluronic acid and collagen type IV as markers of hepatic fibrosis in patients with haemochromatosis and other chronic liver diseases American Association for the Study of Liver Diseases (AASLD) 50th annual meeting. Texas, USA. November 5-9, 1999.

1999

Conference Publication

Fibrosis in chronic rejection of liver allografts occurs in several pathways

Nakazawa, Y., Walker, N. I., Kerlin, P., Strong, R. W., Lynch, S. V. and Clouston, A. D. (1999). Fibrosis in chronic rejection of liver allografts occurs in several pathways. Aust. Academy of Science, Canberra, 14-16 Apr, 1999. Carlton, Vic.: Blackwell Science.

Fibrosis in chronic rejection of liver allografts occurs in several pathways

1999

Journal Article

Role of donor leukocyte chimerism in establishing the etiology of neutropenia after liver transplantation

Jonsson, J. R., Gill, D., Hogan, P. G., Clouston, A. D., Edwards-Smith, C. J., Griffin, A. D., Balderson, G. A., Lynch, S. V., Strong, R. W. and Powell, E. E. (1999). Role of donor leukocyte chimerism in establishing the etiology of neutropenia after liver transplantation. Transplantation, 67 (10), 1358-1361. doi: 10.1097/00007890-199905270-00011

Role of donor leukocyte chimerism in establishing the etiology of neutropenia after liver transplantation

1999

Conference Publication

Quantification of donor leucocytes in pre-transplant liver biopsies: No correlation with graft outcome

Clouston, A., Powell, E., Balderson, G.A., Edwards-Smith, C., Hogan, P. and Lynch, S. V. (1999). Quantification of donor leucocytes in pre-transplant liver biopsies: No correlation with graft outcome. Transplantation Society of Australia and New Zealand 17th Annual Scientific Meeting, Aust. Academy of Science, Canberra, 14-16 Apr, 1999. Canberra: The Transplantation Society of Aust. and New Zealand.

Quantification of donor leucocytes in pre-transplant liver biopsies: No correlation with graft outcome

1999

Conference Publication

Clinicopathological analysis of hepatocellular carcinoma arising in non-cirrhotic liver

Higgins, C., Clouston, A. D., Strong, R. W. and Macdonald, G. A. (1999). Clinicopathological analysis of hepatocellular carcinoma arising in non-cirrhotic liver. American Association for the Study of Liver Diseases, Dallas, USA, 5-9 Nov, 1999. Baltimore: Williams & Wilkins.

Clinicopathological analysis of hepatocellular carcinoma arising in non-cirrhotic liver

1999

Journal Article

Clinicopathologic findings of recurrent primary sclerosing cholangitis after orthotopic liver transplantation.

Kubota, T., Thomson, A., Clouston, A. D., Nakazawa, Y., Steadman, C., Kerlin, P., Shimada, H., Balderson, G. A., Lynch, S. V. and Strong, R. W. (1999). Clinicopathologic findings of recurrent primary sclerosing cholangitis after orthotopic liver transplantation.. Journal of Hepatobiliary Pancreatic Surgery, 6, 377-381.

Clinicopathologic findings of recurrent primary sclerosing cholangitis after orthotopic liver transplantation.

1999

Conference Publication

Serum hyaluronic acid and collagen type IV as markers of hepatic fibrosis in patients with haemochromatosis and other chronic liver diseases

Ramm, G. A., Murphy, T. L., Fanning, P. A., Clouston, A. D., George, D. K., Fletcher, L. M., Anderson, G., Powell, L. W. and Crawford, D. H. (1999). Serum hyaluronic acid and collagen type IV as markers of hepatic fibrosis in patients with haemochromatosis and other chronic liver diseases. American Assoc. for the Study of Liver Diseases 50th Annual Meeting, Dallas, Texas, USA, 5 - 9 Nov, 1999. USA: W B Saunders Co..

Serum hyaluronic acid and collagen type IV as markers of hepatic fibrosis in patients with haemochromatosis and other chronic liver diseases

1999

Conference Publication

Role of donor leukocyte chimerism in establishing the aetiology of neutropenia following liver transplantation

Jonsson, J. R., Gill, D., Hogan, P., Clouston, A. D., Edwards-Smith, C. and Griffin, A. (1999). Role of donor leukocyte chimerism in establishing the aetiology of neutropenia following liver transplantation. -, Canberra, 14th- 16th June, 1999.

Role of donor leukocyte chimerism in establishing the aetiology of neutropenia following liver transplantation

1999

Conference Publication

The effect of anti-TNF-alpha treatment in the rat liver ischaemia/reperfusion model

Saxton, N., Barclay, J., Clouston, A. D. and Fawcett, J. (1999). The effect of anti-TNF-alpha treatment in the rat liver ischaemia/reperfusion model. Transplantation Society of Australia/New Zealand Annual Scientific Meeting, Canberra, 14-16 Jun, 1999. Asia: Blackwell Science.

The effect of anti-TNF-alpha treatment in the rat liver ischaemia/reperfusion model

1999

Journal Article

Fibrosis in chronic hepatitis C correlates significantly with body mass index and steatosis

Hourigan, L. F., Macdonald, G. A., Purdie, D., Whitehall, V. L. J., Shorthouse, C., Clouston, A. and Powell, E. E. (1999). Fibrosis in chronic hepatitis C correlates significantly with body mass index and steatosis. Hepatology, 29 (4), 1215-1219. doi: 10.1002/hep.510290401

Fibrosis in chronic hepatitis C correlates significantly with body mass index and steatosis

1999

Conference Publication

High grade dysplasia in Barrett's oesophagus

Sanders, G., Smithers, B. M., Gotley, D. C. and Clouston, A. (1999). High grade dysplasia in Barrett's oesophagus. ArrayAustralian Gastroenterology Week 1999, Brisbane Convention Cen., 4-8 Oct, 1999. Carlton, Vic.: Blackwell Science, Asia.

High grade dysplasia in Barrett's oesophagus

1999

Conference Publication

Serum hyaluronic acid is a sensitive marker of both cirrhosis in haemochromatosis and liver injury in other chronic liver diseases

Ramm, G. A., Murphy, T. L., Fanning, P. A., Clouston, A. D., George, D. K., Fletcher, L. M., Anderson, G., Powell, L. W. and Crawford, D. H. (1999). Serum hyaluronic acid is a sensitive marker of both cirrhosis in haemochromatosis and liver injury in other chronic liver diseases. Australian Gastroenterology Week 1999, Brisbane, 4 - 8 October,1999. Carlton, Vic: Blackwell Science Asia.

Serum hyaluronic acid is a sensitive marker of both cirrhosis in haemochromatosis and liver injury in other chronic liver diseases

1999

Conference Publication

Venous sclerosis and fibrosis in chronic rejection of liver allografts

Nakazawa, Y., Walker, N. I., Lynch, S. V. and Clouston, A. D. (1999). Venous sclerosis and fibrosis in chronic rejection of liver allografts. 5th Banff Consensus Conference of Allograft Pathology, Banff Springs, Canada, 7-12 June, 1999. Internet: Univ. of Pitsburgh Medical Cen..

Venous sclerosis and fibrosis in chronic rejection of liver allografts

1999

Conference Publication

Veno-occlusive lesions in veins in liver allografts and the relationship to progressive venous sclerosis

Nakazawa, Y., Walker, N. I., Kerlin, P., Strong, R. W., Lynch, S. V. and Clouston, A. D. (1999). Veno-occlusive lesions in veins in liver allografts and the relationship to progressive venous sclerosis. As above, Aust. Academy of Science, Canberra, 14-16 Apr, 1999. Carlton, Vic.: Blackwell Science Asia.

Veno-occlusive lesions in veins in liver allografts and the relationship to progressive venous sclerosis

1999

Journal Article

Spur cell anaemia and hepatic iron stores in patients with alcoholic liver disease undergoing orthotopic liver transplantation

Pascoe, A., Kerlin, P., Steadman, C., Clouston, A. D., Jones, D., Powell, L. W., Jazwinska, E. C., Lynch, S. V. and Strong, R. W. (1999). Spur cell anaemia and hepatic iron stores in patients with alcoholic liver disease undergoing orthotopic liver transplantation. Gut, 45 (2), 301-305. doi: 10.1136/gut.45.2.301

Spur cell anaemia and hepatic iron stores in patients with alcoholic liver disease undergoing orthotopic liver transplantation

1999

Conference Publication

The clinico-pathological features of hepatocellular carcinoma occuring in non-cirrhotic patients

Higgins, C., Clouston, A. D., Strong, R. W. and Macdonald, G. A. (1999). The clinico-pathological features of hepatocellular carcinoma occuring in non-cirrhotic patients. Australian Gastroenterology Week 1999, Brisbane, 4-8 Oct, 1999. Carlton, Vic: Blackwell Science.

The clinico-pathological features of hepatocellular carcinoma occuring in non-cirrhotic patients

1999

Conference Publication

Iron overload in end-stage liver disease: Relationship to disease severity and post-transplant outcome

Stuart, K. A., Fletcher, L. M., Clouston, A., Purdie, D. M., Lynch, S. V., Kerlin, P. and Crawford, D. H. (1999). Iron overload in end-stage liver disease: Relationship to disease severity and post-transplant outcome. Australian Gastroenterology Week 1999, Brisbane, 4-8 October, 1999. Carlton, Vic: Blackwell Science.

Iron overload in end-stage liver disease: Relationship to disease severity and post-transplant outcome

1999

Conference Publication

Clinicopathological analysis of hepatocellular carcinoma occuring in non-cirrhotic patients

Higgins, C. M., Clouston, A. D., Strong, R. W. and Macdonald, G. A. (1999). Clinicopathological analysis of hepatocellular carcinoma occuring in non-cirrhotic patients. Australian Gastroenterology Week 1999, Brisbane Convention Centre, 4-8 October, 1999. Carlton South, Vic.: Blackwell Publishing Asia.

Clinicopathological analysis of hepatocellular carcinoma occuring in non-cirrhotic patients

1999

Conference Publication

Serum collagen type IV and hyaluronic acid as markers of hepatic fibrosis in patients with haemochromatosis and other chronic liver diseases

Ramm, G. A., Murphy, T. L., Fanning, P. A., Clouston, A. D., George, D. K., Fletcher, L. M., Anderson, G., Powell, L. W. and Crawford, D. H. (1999). Serum collagen type IV and hyaluronic acid as markers of hepatic fibrosis in patients with haemochromatosis and other chronic liver diseases. Bioiron'99, Sorrento Palace, Sorrento - Naples, Italy, 23 - 28 May 1999. Italy: SGC.

Serum collagen type IV and hyaluronic acid as markers of hepatic fibrosis in patients with haemochromatosis and other chronic liver diseases

Funding

Past funding

  • 2019 - 2022
    CSF1 Therapy for Chronic Liver Disease
    NHMRC Project Grant
    Open grant
  • 2015 - 2019
    A La CaRT: Australasian Laparoscopic Cancer of the Rectum Trial. A phase III prospective randomised trial comparing laparoscopic-assisted ... (NHMRC Project Grant administered by University of Sydney)
    University of Sydney
    Open grant
  • 2015 - 2016
    Identifying Protective v Pathogenic Macrophages in Chronic Liver Disease: Critical for Macrophage-Targeted Therapy
    PA Research Foundation
    Open grant
  • 2013 - 2014
    Targeting the Wnt Pathway: Implication for Chronic Liver disease
    PA Research Foundation
    Open grant
  • 2013 - 2015
    Defining the role of MMP-9-expressing macrophages in liver injury in chronic liver disease
    NHMRC Project Grant
    Open grant
  • 2011 - 2013
    Monocytes/macrophages in chronic liver diseases: cross-talk with hepatocytes and nonparenchymal cells and role in progressive liver injury
    NHMRC Project Grant
    Open grant
  • 2008 - 2010
    Role of obesity in impaired treatment response in chronic hepatitis C: mechanisms and therapeutic strategies
    NHMRC Project Grant
    Open grant
  • 2007 - 2009
    Hepatocyte replicative arrest, hepatic progenitor cells and the ductular reaction in hepatic fibrogenesis
    NHMRC Project Grant
    Open grant
  • 2006 - 2009
    The Role Of Hepatic Progenitor Cells And A Ductular Reaction In Disease Progression In Non-Alcoholic Fatty Liver Disease
    Princess Alexandra Hospital R&D Foundation
    Open grant
  • 2005
    The effect of obesity on liver function in children who are long term liver transplant recipients
    Royal Children's Hospital Foundation
    Open grant
  • 2005 - 2007
    The role of steatosis in promoting cellular injury and fibrogenesis in human liver disease
    NHMRC Project Grant
    Open grant
  • 2004 - 2005
    The Effect Of Alcohol On Hepatitis C-Induced Liver Disease
    Australian Brewers' Foundation
    Open grant
  • 2002 - 2004
    Investigation of the role of the renin-angiotensin system in hepatic fibrosis
    NHMRC Project Grant
    Open grant
  • 2002
    Strategies to monitor graft acceptance following human liver transplantation
    Princess Alexandra Hospital R&D Foundation
    Open grant
  • 2001 - 2002
    Investigation of the role of the renin-angiotensin system in hepatic fibrosis
    Mayne Bequest Fund
    Open grant
  • 2001
    Fibrosis after liver transplantation - role of the renin angiotensin system
    Royal Children's Hospital Foundation
    Open grant
  • 2001
    Hepatitis C virus and the host: Viral effects on lipid metabolism and fibrogenesis
    Princess Alexandra Hospital R&D Foundation
    Open grant
  • 2001
    Investigation of the role of the renin-angiotensin system in hepatic fibrosis
    Princess Alexandra Hospital R&D Foundation
    Open grant
  • 2000
    Investigation of the relationship between steatosis, lipid peroxidation and fibrosis in chronic hepatitis C
    Princess Alexandra Hospital R&D Foundation
    Open grant
  • 1999
    Donor leucocytes contribute to liver allograft acceptance: investigation of a mechanism
    Royal Children's Hospital Foundation
    Open grant
  • 1999
    Fine needle aspiration of liver grafts to monitor apoptosis of graft infiltrating leucocytes
    Princess Alexandra Hospital R&D Foundation
    Open grant
  • 1998
    Cytokine modulation ofliver associated leucocyte proliferation and cytotoxicity
    Royal Children's Hospital
    Open grant
  • 1997
    Characterisation of leucocytes derived from human liver preservation perfusate: a new form of donor-specific transfusion?
    Princess Alexandra Hospital R&D Foundation
    Open grant
  • 1997
    Frequency and distribution of cytokine expression in liver allograft rejection
    University of Queensland New Staff Research Grant
    Open grant
  • 1997
    Mechanisms by which liver-derived leucocytes may promote human graft acceptance
    Royal Children's Hospital Foundation
    Open grant
  • 1996
    Characterization of chimeric leucocytes following human liver transplantation
    Mayne Bequest Fund
    Open grant

Supervision

Availability

Professor Andrew Clouston is:
Available for supervision

Before you email them, read our advice on how to contact a supervisor.

Media

Enquiries

For media enquiries about Professor Andrew Clouston's areas of expertise, story ideas and help finding experts, contact our Media team:

communications@uq.edu.au